ATP2A1 and myotonic dystrophy type 1: Treatment of either normal or DM1 fibroblasts with ISOX and Vorinostat produced a significant increase of MBNL1 levels, and partially rescued the splicing of SERCA1 e22 and INSR e11 in both cell lines (Table S1 in Supplementary Material).